Dicerna Pharmaceuticals
DRNA
$38.22
Share price
0.00%
Change (1 day)
17,272.73%
Change (1 year)
Categories
Market capitalization of Dicerna Pharmaceuticals (DRNA)
Market cap: $2.97 Billion
As of May 2022 Dicerna Pharmaceuticals has a market cap of $2.97 Billion. This makes Dicerna Pharmaceuticals the world's 3014th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Dicerna Pharmaceuticals from 2014 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $2.97 B | |
| 2021 | $2.97 B | 78.42% |
| 2020 | $1.66 B | 5.85% |
| 2019 | $1.57 B | 116.24% |
| 2018 | $0.72 B | 56.37% |
| 2017 | $0.46 B | 680.22% |
| 2016 | $0.05 B | -75.55% |
| 2015 | $0.24 B | -16.55% |
| 2014 | $0.29 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $286.80 B | 9,531.63% | 🇺🇸 USA |
 Amgen AMGN | $130.94 B | 4,297.46% | 🇺🇸 USA |
 Merck MRK | $236.11 B | 7,829.44% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $0.02 B | -99.03% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $15.58 B | 423.25% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $3.64 B | 22.40% | 🇺🇸 USA |